COMP <GO>
MED vs PEP // FREE CASH FLOW YIELD
MEDIFAST INC (NYSE) VS. PepsiCo Inc. (NASDAQ) • 15-METRIC TALLY: MED 3
— PEP 7
▲ FREE CASH FLOW YIELD LEADER: PEP
LAST: $12.26 (-0.16%) • MKT CAP: $137.1M
fcf-yield
0.91%
LAST: $133.79 (+0.88%) • MKT CAP: $182.32B
fcf-yield
4.31%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MED VS. PEP)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MED | PEP | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 71.30% | 54.10% | +17.20 | MED | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -10.20% | 17.00% | -27.20 | PEP | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 14.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 0.91% | 4.31% | -3.40 | PEP | /fcf-yield <GO> |
| Operating Margin | -3.70% | 12.20% | -15.90 | PEP | /operating-margins <GO> |
| Net Profit Margin | -4.90% | 8.80% | -13.70 | PEP | /net-margins <GO> |
| Revenue Growth (YoY) | -36.00% | 2.30% | -38.30 | PEP | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.14% | 4.19% | -4.05 | PEP | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.71 | 3.38 | +1.33 | MED | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 5/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.7 | 52.4 | +4.30 | MED | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.89 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 20.6x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $137.1M | $182.32B | -$182.18B | PEP | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MED REV | PEP REV | MED GROSS % | PEP GROSS % | MED FCF | PEP FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $385.8M | $93.92B | 71.3% | 54.1% | $1.2M | $7.86B |
| FY 2024 | $602.5M | $91.85B | 73.8% | 54.6% | $17.0M | $8.37B |
| FY 2023 | $1.07B | $91.47B | — | — | $147.7M | $9.33B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MED // BETA —
PEP // BETA 0.89